| |
Omnyx is focused on innovation in pathology. Our products are in development, and we are dedicated to making the most complete, fastest, and most accurate integrated digital pathology solution—one that will enable anatomic pathologists in hospitals to render diagnosis from a digital image. Through our digitized workflow, pathologists will enjoy a new level of efficiency and usability never before experienced at their bench.
Uniting two leaders in technology and healthcare
As a joint venture of GE Healthcare and University of Pittsburgh Medical Center (UPMC), Omnyx draws from each partner’s deep roots in engineering and clinical excellence.
GE Healthcare has experience in clinical radiology and cardiology in hospitals worldwide, and Omnyx will build on GE Healthcare’s proven device research and next generation medical software platforms. As a recognized leader in digital pathology, UPMC will guide the product design and serve as a proving ground within its network of hospitals and labs.
|
Gene Cartwright, CEO
Gene.Cartwright@omnyx.com
Gene Cartwright joined GE Healthcare in 2005 as President of Molecular Diagnostics as the pioneer of GE’s entrance in the molecular diagnostics space. He successfully started the foundation of the business, entrepreneur of GE’s position in the market and successfully weaved developments across the portfolio for commercialization in the space.
Prior, Gene Cartwright spent 23 years at Abbott Laboratories where he began his distinguished career in 1982 as a research scientist to ultimately becoming Abbott’s Vice President of Strategic Programs for its molecular diagnostics business.
While at Abbott, Gene honed his reputation as a leader in molecular diagnostics strategy by playing a key role in building Abbott’s successful diagnostics business in a variety of roles. In his early career, he worked in diagnostics manufacturing and led quality and the FDA submissions for Abbott’s cancer diagnostics products. As Abbott’s Vice President and General Manager of Molecular Diagnostics he was responsible for marketing, manufacturing, research, and product development. This evolved into his role leading strategic programs which included business development, partner relations, reimbursement strategies, and sales to Abbott’s key global customers.
|
|
Andrew Chomos, VP Finance and Operations
Andrew.Chomos@omnyx.com
Andrew Chomos recently served as CEO of Caracal Inc, an early stage advanced materials manufacturer located in Ford City, PA. He led the company from R&D stage in 2005 to commercialization in 2006. Andrew was an integral liaison for Department of Defense contracting as well as private sector customers worldwide. He also secured funding for the company in excess of $10M from both private and public sources.
From 1991 through early 2005, Andrew served in a dual role as Chief Financial Officer and Chief Operating Officer of Ritter Technology LLC, a $60 million hydraulics and pneumatics distributor for Parker Hannifin (NYSE PH), with 12 locations in four States. He has a strong track record of profitable operations, ISO 9000 Quality Assurance Certifications, human resources, risk management, strong financial reporting, and internal controls.
As a practicing Certified Public Accountant with Ernst & Young for five years prior to joining Ritter, Andrew brings a strong balance of financial wherewithal and operations excellence to the Omnyx team.
|
|
Rajiv Enand, Senior VP Business Development
Rajiv.Enand@omnyx.com
Rajiv Enand is a veteran technology entrepreneur in western Pennsylvania and now Senior Vice President at Omnyx, managing strategic business relationships for the company. Prior to joining Omnyx, Mr. Enand was an executive in UPMC’s Strategic Business Initiatives organization, overseeing more than $170 million worth of investment activity aimed at creating and marketing a variety of advanced technologies focused on improving patient care or managing costs in the health care market. In this role, he managed relationships with such key development and investment partners as IBM, GE, Cerner, Alcatel-Lucent and Carnegie Mellon University. Omnyx was born out of the GE joint development fund initiative, which he managed.
Before joining UPMC in 2006, Mr. Enand was a co-founder of Caracal Inc., an advanced semiconductor materials company. With more than $9.5 million in startup funds, Caracal converted a brownfield site in Ford City, Pa., into an advanced technology manufacturing company and helped to revitalize a depressed community. Mr. Enand was also a co-founder and CEO of ServiceWare, an IT help desk software company, which he led to an IPO in 2000. He has served on the boards of several early-stage technology companies and is a founding member of TiE Pittsburgh, a networking group for technology entrepreneurs.
|
|
Michael Meissner, VP Software Research and Development
Michael.Meissner@omnyx.com
Dr. Michael Meissner received his M.S. in Computer Science from the Karls Eberhard University in Tübingen, Germany, in 1996. During his masters degree, he was a visiting student at the SUNY Stony Brook, NY and at Hewlett Packards Research Laboratory in Palo Alto, CA. At both institutions he investigated volume rendering techniques and efficient hardware acceleration approaches for these.
After receiving his M.S. degree, Michael intensified his studies and pursued a Ph.D. in Computer Science in the field of 3D computer graphics, specifically applied to Medical Imaging. In 2001 he joined Viatronix, a Radiology based Imaging Solution company with a flagship product in Virtual Colonoscopy. At Viatronix, he started as Senior Software Developer, architected their extendible application framework, and advanced to Director R&D.
After 4 years, he joined Vital Images where he lead the development of a client-server based enterprise-wide advanced visualization system (ViTALConnect) which required tight collaboration with the development team in Beijing, China. After two successful product releases, Michael advanced to Vice President of Engineering, coordinating efforts of a 115 engineers.
|
|
Tony Melanson, VP Strategy and Marketing
Tony.Melanson@omnyx.com
Tony Melanson has been a thoughtful innovator in the software industry for the past 15 years. During this time he has worked for software companies ranging from privately held startup firms to a global enterprise software vendor. He has held positions in development, consulting, product management, and strategic marketing.
Typically, Tony is found advancing new products, services, and strategies that solve customer problems and create growth opportunities for his company. Prior to Omnyx he was responsible for new market development and business planning for a unit within GE Healthcare Integrated IT Solutions.
Tony holds a bachelor’s degree from the Whittemore School of Business at the University of New Hampshire.
|
|
Mike Montalto, VP Research and Instrument Development
Michael.Montalto@omnyx.com
Mike Montalto received his Ph.D. in Cell Biology from Albany Medical College in 1999. He received his post-doctoral training and served as an Instructor of Anesthesia at Harvard Medical School, Brigham and Women’s Hospital from 1999 to 2001.
Following his training, he joined GE Global Research as a lead scientist. He became the Program Leader for the Molecular Imaging and Diagnostics Advanced Technology Program in 2004, and the lab manager for the Cell and Molecular Biology Laboratory in 2007. While at GE he led a team of 60 engineers, biologists, and chemists aimed at incubating long-term research for in vivo molecular imaging and molecular and digital pathology.
Dr. Montalto has previous work experience as a research histotechnician at Memorial Sloan Kettering Cancer Center and as a clinical serology technician at Albany Medical Center. He is an Adjunct Assistant Professor of Neuroscience and Neuropharmacology at Albany Medical College and served as a full member of the NIH Study Section for In Vivo Cellular and Molecular Imaging Centers.
|
|
Anthony Demetris, MD
Dr. Anthony Demetris, M.D. is Professor of Pathology and Director of the Division of Liver and Transplantation Pathology. He has authored more than 500 scientific publications. He co-developed, along with Dr. Marta Minervini, a static image and remote-microscopy based clinical telepathology system between UPMC-Pittsburgh and UPMC-Palermo, Italy (ISMETT), which has been operative and in use for the last eight years.
Dr. Demetris is also Director of the Liver Tissue Core for the Immune Tolerance Network of whole slide images (digital archive) of all samples for internet-based viewing of the slides, reporting of results, and analysis using open-source image analysis software.
|
|
Jeffrey Fine, MD
Dr. Jeffrey Fine is a practicing breast and gynecologic pathologist at the University of Pittsburgh Medical Center, where he is also a member of the Pathology Department's Division of Pathology Informatics. He completed residency training at the Cleveland Clinic and a pathology informatics fellowship at the University of Pittsburgh. Dr. Fine's research interests include: clinical applications of digital imaging (including whole slide images, image analysis, and telepathology); automation of the anatomic pathology laboratory; and enhancements of anatomic pathology laboratory information systems (APLIS).
|
|
Jonhan Ho, MD
Dr. Jonhan Ho is a board certified dermatopathologist with board certifications in anatomic pathology, clinical pathology, and dermatopathology. He is a faculty member of the University of Pittsburgh, School of Medicine, in the Department of Dermatology, where he is the Director of Dermatopathology Resident Education. Dr. Ho also has a secondary appointment in the Department of Pathology.
Prior to his dermatopathology fellowship training, Dr. Ho completed a pathology informatics fellowship at the University of Pittsburgh, where he is also currently pursuing a Masters degree in the Department of Biomedical Informatics. Dr. Ho has several publications in the field of digital pathology and has been invited to speak on implementation of digital pathology at multiple national meetings. His research focuses on human computer interaction and translating digital slide technology into practice.
|
|
Drazen Jukic, MD, PhD
Dr. Jukic is an assistant professor in the departments of dermatology and pathology at the University of Pittsburgh School of Medicine. He is also a director of dermatopathology fellowship, dermatopathology unit and the medical director of histology and immunohistochemistry at UPMC Shadyside, as well as an active member of the melanoma group of the University of Pittsburgh Cancer Institute. Dr. Drazen’s research efforts center around digital anatomic pathology, including telemedicine and bioinformatics. He is a member of a Digital Pathology Imaging Group (DPIG), is a part of The Division of Pathology Informatics and the Department of Pathology, and is actively involved in creating and maintaining a large digital storage facility for whole slide imaging, digital imaging, and telepathology.
Dr. Jukic has served in several appointed positions in organized medicine, including as a delegate for the American Medical Association, American Society of Clinical Pathologists as well as Committee of Interns and Residents in New York City. He is currently serving as a spokesperson for the College of American Pathologists and a delegate from the State of Pennsylvania to the same organization.
Dr. Jukic completed his medical degree at the University of Zagreb Medical School in Croatia and completed his Ph.D. in the field of oncology at the University of Zagreb.
|
|
Anil V. Parwani, M.D., PhD
Anil Parwani is Director of Division of Pathology Informatics, Department of Pathology and an active member of the Genito-Urinary Pathology Center of Excellence, University of Pittsburgh Medical Center Shadyside. Dr. Parwani's research interests include Urologic Pathology, with focus on high throughput analysis of immunohistochemical markers for diagnosis of prostate carcinoma using tissue microarrays, benign mimickers of prostate carcinoma, and correlation of histomorphological features of renal cell carcinoma with cytogenetic and molecular changes. Other research interests are in the area of Anatomical Pathology Informatics including design of quality assurance tools, synoptic reporting in anatomical pathology, clinical applications of whole slide imaging, digital imaging, telepathology, image analysis and lab automation, and workflow processes such as barcoding.
|
|
Michael J. Becich, MD, PhD
Dr. Michael J. Becich is a Professor of Biomedical Informatics and the founding chair of a new Department of Biomedical Informatics at the University of Pittsburgh Medical School. He is jointly appointed as Professor of Pathology as well as Information Sciences and Telecommunications.
Dr. Becich holds an MD and a PhD in Experimental Pathology form Northwestern University and his research interests are in cancer biology and biomedical informatics. His current research focuses on developing tools to couple clinical data (phenomics) to expression data derived from high throughput genomics and proteomics and imaging repositories.
He leads the University of Pittsburgh Cancer Institute’s participation in the Cancer Biomedical Informatics Grid and is co-director of the University of Pittsburgh Medical School’s newly funded Clinical and Translational Science Institute. He was a founder of two startups, Tissue Informatics and InterScope Technologies (formerly Trestle Corp), which were merged into Clinical Data and Zeiss.
Dr. Becich is an expert in whole slide imaging applied to clinical and research issues in Pathology. He is a member of 13 professional societies and has published more than 140 papers that contribute to the mission of Biomedical Informatics as applied to Translational Medicine. Of note, Dr. Becich has hosted Advancing Practice, Instruction and Innovation through Informatics (APIII), a transformational scientific conference that is currently in its 13th year and has provided more than 200 educational awards to trainees in informatics. APIII 2008 will focus on imaging informatics initiatives and the synergy between radiology and pathology imaging.
|
|
George K. Michalopoulos, MD, PhD
Read Bio
George K. Michalopoulos, MD, PhD
George K. Michalopoulos received his medical doctoral degree at Athens University School of Medicine in 1969. He obtained a residency in Anatomic Pathology and a Ph.D. in Oncology at the Wisconsin Medical Center in Madison in 1977. Dr. Michalopoulos moved to Duke University as Assistant Professor in 1977 and stayed at Duke University until 1991. He then moved to Pittsburgh as Professor and Chairman of the Department of Pathology in April, 1991. He served as Associate Vice Chancellor for Health Sciences and Interim Dean of the School of Medicine from November, 1995, until November, 1998. His work focuses on molecular pathways related to liver regeneration and liver pathology.
|
Omnyx Licenses Olympus Digital Pathology Patents
CENTER VALLEY, Pa., March 1, 2010
Olympus America Inc. has signed a nonexclusive worldwide licensing agreement with Omnyx, LLC, a joint venture of GE Healthcare and the University of Pittsburgh Medical Center, allowing Omnyx to access an extensive portfolio of Olympus America patents in the field of virtual microscopy and digital pathology.
More
Frost & Sullivan Recognizes Omnyx for Strategic Leadership in Digital Pathology.
Pittsburgh, PA - November 30, 2009
 “Over the last few years, a change in mindset has been evident in the pathology area, with increasing demands for automating the processes that take place in the laboratory – from improving the workflow to supporting better and faster care, and meeting the demands for advanced data management."
More
How is Omnyx solving the throughput-quality-tradeoff for digital pathology?
Pittsburgh, PA - October 12, 2009
 Accurate focusing is a critical challenge of whole slide imaging, primarily due to inherent tissue topology variability. Traditional line scanning and tile-based scanning systems are limited in their ability to acquire a high degree of focus points while still maintaining high throughput.
More
|
|
|
